Cadrenal Therapeutics, Inc. Stock Issued During Period, Shares, Restricted Stock Award, Gross
Cadrenal Therapeutics, Inc. (CVKD) had Stock Issued During Period, Shares, Restricted Stock Award, Gross of 25.00 thousand shares as of 2025-01-08, per its 10-K filed 2026-03-31.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross · last filed 2026-03-31
- 2025-01-08: Stock Issued During Period, Shares, Restricted Stock Award, Gross 25.00K shares.
- 2022-07-11: Stock Issued During Period, Shares, Restricted Stock Award, Gross 46.88K shares.
| Period end | Stock Issued During Period, Shares, Restricted Stock Award, Gross |
|---|---|
| 2025-01-08 | 25.00K shares 10-K · filed 2026-03-31 |
| 2022-07-11 | 46.88K shares 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B |